Cambria Investment Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.96M Buy
7,734
+2,727
+54% +$636K 0.1% 199
2026
Q1
$1.22M Sell
5,007
-304
-6% -$70.8K 0.07% 200
2025
Q4
$1.1M Buy
5,311
+2,306
+77% +$456K 0.06% 233
2025
Q3
$557K Buy
+3,005
New +$515K 0.03% 341
2019
Q4
Sell
-33,266
Closed -$4.3M 208
2019
Q3
$4.3M Buy
33,266
+438
+1% +$57.7K 0.65% 67
2019
Q2
$4.57M Buy
32,828
+990
+3% +$137K 0.7% 66
2019
Q1
$4.45M Buy
31,838
+1,146
+4% +$154K 0.69% 65
2018
Q4
$3.96M Sell
30,692
-2,920
-9% -$407K 0.67% 57
2018
Q3
$4.64M Sell
33,612
-565
-2% -$75.1K 0.68% 44
2018
Q2
$4.22M Sell
34,177
-1,404
-4% -$175K 0.63% 69
2018
Q1
$4.56M Sell
35,581
-8,186
-19% -$1.11M 0.66% 62
2017
Q4
$6.12M Buy
43,767
+5,189
+13% +$723K 0.85% 52
2017
Q3
$5.02M Buy
38,578
+23,408
+154% +$3.1M 0.77% 62
2017
Q2
$2.01M Buy
+15,170
New +$1.94M 0.43% 67

Other funds holding JNJ

Cambria Investment Management's JNJ Position: Q2 2026 in Review

Cambria Investment Management increased its Johnson & Johnson (JNJ) stake by 54% in Q2 2026, buying an estimated $636K and bringing the position to 7,734 shares worth $1.96M. The position accounts for 0.1% of the portfolio, ranked #199.

Cambria Investment Management first reported a position in JNJ in Q2 2017 and has held it in 14 quarters since. The position peaked at $6.12M in Q4 2017. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Cambria Investment Management held 7,734 shares of Johnson & Johnson worth $1.96M as of Q2 2026.
  • Cambria Investment Management bought 2,727 Johnson & Johnson shares in Q2 2026, an estimated $636K.
  • Johnson & Johnson made up 0.1% of Cambria Investment Management's portfolio in Q2 2026, its #199 holding.
  • Cambria Investment Management first reported a position in Johnson & Johnson in Q2 2017 and has held it in 14 quarters since.
  • Cambria Investment Management's Johnson & Johnson position peaked at $6.12M in Q4 2017.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Cambria Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.